This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

European Markets For Diabetes Monitoring, Treatment And Drug Delivery









NEW YORK, Feb. 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

European Markets for Diabetes Monitoring, Treatment and Drug Delivery

http://www.reportlinker.com/p01093084/European-Markets-for-Diabetes-Monitoring-Treatment-and-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

 

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019.

This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

 

Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

 

Report Contents:

- Competitor Analysis

- Identified Strategic Opportunities

- Market Overview by Segment & Country

- Trend Analysis by Segment & Country

- Market Drivers & Limiters

- Mergers & Acquisitions

- Customer Feedback and Market Monitoring

 

Main Segments Included:

- Traditional blood glucose monitoring

- Blood glucose meters

- Blood glucose test strips

- Lancets and lancing devices

- Insulin

- Insulin syringes

- Insulin pens

- Insulin pumps

- Artificial pancreas

 

 

Companies Listed in Report:

- Sanofi

- Johnson & Johnson

- Eli Lilly

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs